Cambridge Enterprise helps the University of Cambridge's researchers & academics to commercialise their ideas for the benefit of society.
University of Cambridge Enterprise, also known as Cambridge Enterprise Seed Funds, consisting of the Challenge Fund and the Venture Fund, is a resource for members of the University of Cambridge and the Babraham Institute. Investments are priced and structured competitively with other sources of early stage seed capital in order to encourage co-investment, follow-on funding and commercialisation of University of Cambridge and Babraham Institute inventions.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 3, 2016
Carrick Therapeutics
|
Series A | $95M | Biotechnology | — |